Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders

Clinical Transplantation

Volumn 13, Issue 1 I, 1999, Pages 39-44

  Nalesnik, Michael A ^a,b,c   Zeevi, Adriana ^a,b   Randhawa, Parmjeet S ^a,b   Faro, Albert ^b,d   Spichty, Kathy J ^a,b   Demetris, Anthony J ^a,b   Fung, John J ^a,b   Whiteside, Theresa L ^a,c   Starzl, Thomas E ^a,c  

^a Department of Pathology ^*  (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Epstein Barr virus; Interleukin 10; Interleukin 4; Lymphoma; Lymphoproliferative disorder; Organ transplantation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; HELPER CELL; HUMAN; HUMAN TISSUE; LUNG LAVAGE; LYMPHOPROLIFERATIVE DISEASE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033025683     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.1999.t01-2-130106.x     Document Type: Article

References (23)

1. HARRIS NL, FERRY JA, SWERDLOW SH. Post-transplant lymphoproliferative disorders (PTLD): summary of Society for Hematopathology Workshop. Semin Diag Pathol 1997: 14: 8.
2. HANTO DW, GAJL-PECZALSKA KJ, FRIZZERA G, ARTHUR DC, BALFOUR JR HH, MCCLAIN K, SIMMONS RL, NAJARIAN JS. Epstein - Barr (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Ann Surg 1983: 198: 356.
3. KLEIN G. Epstein - Barr virus strategy in normal and neoplastic B cells. Cell 1994: 77: 791.
4. PENN I. Immunosuppression - a contributing factor in lymphoma formation. Clin Transplant 1992: 6: 214.
5. HESLOP HE, BRENNER MK, ROONEY C, KRANCE RA, ROBERTS WM, ROCHESTER R, SMITH CA, TURNER V, SIXBEY J, MOEN R, BOYETT JM. Clinical Protocol. Administration of neomycin resistance gene marked EBV specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Hum Gene Ther 1994: 5: 381.
6. STARZL TE, NALESNIK MA, PORTER KA, HO M, IWATSUKI S, GRIFFITH BP, ROSENTHAL JT, HAKALA TR, SHAW JR. BW, HARDESTY RL, ATCHISON RW, JAFFE R, BAHNSON HT. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984: i: 583.
7. FARO A, KURLAND G, MICHAELS MG, DICKMAN PS, GREALLY PG, SPICHTY KJ, NOYES BB, BOAS SR, FRICKER FJ, ARMITAGE JM, ZEEVI A. Interferon-alpha affects the immune response in post-transplant lymphopro liferative disorder. Am J Respir Crit Care Med 1996: 153: 1442.
8. WU TT, SWERDLOW SH, LOCKER J, BAHLER D, RANDHAWA P, YUNIS EJ, DICKMAN PS, NALESNIK MA. Recurrent Epstein Barr virus-associated lesions in organ transplant recipients. Hum Pathol 1996: 27: 157.
9. MOSMANN TR, COFFMAN RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989: 7: 145.
10. IACONO A, DAUBER J, KEENAN R, SPICHTY K, CAI J, GRGURICH W, BURKART G, SMALDONEF G, PHAM S, OHORI NP, YOUSEM S, WILLIAMS P, GRIFFITH B, ZEEVI A. Interleukin-6 and gamma interferon gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporin A. Transplantation 1997: 64: 263.
11. MITRUKA SN, PHAM SM, ZEEVI A, LI S, CAI J, BURCKART GJ, YOUSEM SA, KEENAN RJ, GRIFFITH BP. Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation. J Thorac Cardiovasc Surg 1998: 115: 28.
12. MATHUR A, KAMAT DM, FILIPOVICH AH, STEINBUCH M, SHAPIRO RS. Immunoregulatory abnormalities in patients with Epstein - Barr virus-associated B cell lymphoproliferative disorders. Transplantation 1994: 57: 1042.
13. BURKE GW, CIROCCO R, HENSLEY G, REDDY R, JEFFERS L, SCHIFF E, MILLER J. The rapid development of a fatal, disseminated B cell lymphoma following liver transplantation - serial changes in levels of soluble serum interleukin 2 and interleukin 4 (B cell growth factor). Transplantation 1992: 53: 1148.
14. HOWARD MC, MIYAJIMA A, COFFMAN R. T-cell-derived cytokines and their receptors. In: Paul WE, ed. Fundamental Immunology, third edition. New York: Raven Press, 1993.
15. AZZAWI M, HASLETON PS, GRANT SCD, STEWART JP, HUTCHINSON IV. Interleukin-10 in human heart transplantation: an in situ hybridization study. J Heart Lung Transplant 1994: 14: 519.
16. XU GP, SHARMA VK, LI B, BOLOGA R, LI Y, MOURADIAN J, WANG J, SERUR D, RAO V, STENZEL KH, SUTHANTHIRAN M. Intragraft expression of IL-10 messenger RNA: a novel correlate of renal allograft rejection. Kid Internal 1995: 48: 1504.
17. BEATTY PR, KRAMS SM, MARTINEZ OM. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol 1997: 158: 4045.
18. RANDHAWA P, WHITESIDE T, ZEEVI A, NALESNIK M, ALVARES C, GOLLIN SM, DEMETRIS J, LOCKER J. In vitro culture of B-lymphocytes derived from Epstein Barr virus-associated post-transplant lymphoproliferative disease: cytokine production and effect of interferon alpha. In Vitro Cell Dev Biol 1997: 33: 803.
19. KANNO H, NAKA N, YASUNAGA Y, IUCHI K, YAMAUCHI S, HASHIMOTO M, AOZASA K. Production of the immunosuppressive cytokine interleukin-10 by Epstein - Barr-virus-expressing pyothorax-associated lymphoma. Possible role in the development of overt lymphoma in immunocompetent hosts. Am J Pathol 1997: 150: 349.
20. RANDHAWA PS, DEMETRIS AJ, NALESNIK MA. The potential role of cytokines in the pathogenesis of Epstein -Barr virus associated post-transplant lymphoproliferative disease. Leuk Lymphoma 1994: 15: 383.
21. PAPADOPOULOS EB, LADANYI M, EMANUEL D, MACKINNON S, BOULAD F, CARABASI MH, CASTRO-MALASPINA H, CHILDS BH, GILLIO AP, SMALL TN, YOUNG JW, KERNAN NA, O'REILLY RJ. Infusions of donor leukocytes to treat Epstein - Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994: 330: 1185.
22. ROONEY CM, SMITH CA, NG CYC, LOFTIN S, LI C, KRANCE RA, BRENNER MK, HESLOP HE. Use of gene-modified virus-specific T lymphocytes to control Epstein -Barr-virus-related lymphoproliferation. Lancet 1995: 345: 9.
23. NALESNIK MA, RAO AS, FURUKAWA H, PHAM S, ZEEVI A, FUNG JJ, KLEIN G, GRITSCH HA, ELDER E, WHITESIDE TL, STARZL TE. Autologous lymphokine-activated killer cell therapy of Epstein - Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. Transplantation 1997: 63: 1200.